Format

Send to

Choose Destination
See comment in PubMed Commons below
J Vet Emerg Crit Care (San Antonio). 2015 Sep-Oct;25(5):597-605. doi: 10.1111/vec.12322. Epub 2015 Jun 18.

A randomized, controlled clinical trial of intravenous lipid emulsion as an adjunctive treatment for permethrin toxicosis in cats.

Author information

  • 1School of Veterinary and Life Sciences, Murdoch University, 90 South Street, Murdoch, 6150, Western Australia.

Abstract

OBJECTIVE:

To assess for any clinical benefit of intravenous lipid emulsion (ILE) for permethrin toxicosis in cats by comparing the progression of clinical signs of cats before and after treatment with ILE to cats treated with a saline control. To accomplish this objective, a clinical staging system for cats with permethrin toxicosis was developed and validated.

DESIGN:

Prospective, multicenter, randomized, controlled clinical trial.

SETTING:

University veterinary teaching hospital and 12 private veterinary emergency hospitals.

ANIMALS:

Thirty-four client-owned cats with permethrin toxicosis.

INTERVENTIONS:

A clinical staging system was designed based on abnormalities found on physical examination of cats with permethrin toxicosis. The clinical staging system had 6 stages, ranging from Stage A for cats with no abnormalities to Stage F for cats with grand mal seizures. The system was validated for intraviewer and interviewer variability. Cats in the clinical trial were randomized to receive 15 mL/kg of either intravenous 0.9% saline (control) or 20% ILE over 60 minutes. For each cat, a clinical stage was recorded at set time points before and after the randomized treatment was administered. The distribution of clinical stage stratified over time was compared across treatment groups.

MEASUREMENTS AND MAIN RESULTS:

The clinical staging system showed excellent repeatability (P = 1.0) and reliability (P = 1.0). In the clinical trial, there was a significant difference in the distribution of clinical stages over time (P < 0.001) and from presentation stage to Stage B (P = 0.006), with ILE-treated cats (n = 20) having lower clinical stages earlier than control cats (n = 14). There was no significant difference in signalment, body weight, or supportive treatment between the groups.

CONCLUSIONS:

The clinical staging system was repeatable and reliable. Clinical stages of permethrin toxicosis in ILE-treated cats improved earlier compared to control cats, suggesting ILE may be a useful adjunctive therapy in the treatment of permethrin toxicosis in cats.

KEYWORDS:

feline; intralipid therapy; methocarbamol; toxicology

PMID:
26088727
DOI:
10.1111/vec.12322
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center